4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-22-056007
Options or other derivatives
- Chief Scientific Officer acquired 557,304 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Brewer Joanna Elizabeth Chief Scientific Officer | 2022-05-04 | Grant or award · Option to purchase Ordinary Shares | +333,792 | 333,792 | D | ||
| Brewer Joanna Elizabeth Chief Scientific Officer | 2022-05-04 | Grant or award · Option to purchase Ordinary Shares | +223,512 | 223,512 | D | ||
Loading xslF345X03/tm2214456-2_4seq1.xml…